The role of lymphangiogenesis in lymphatic tumour spread of urological cancers

BJU International

Volumn 104, Issue 5, 2009, Pages 592-597

  Bolenz, Christian ^f   Fernández, Mario I ^e   Tilki, Derya ^b   Herrmann, Edwin ^c   Heinzelbecker, Julia ^a   Ergün, Süleyman ^d   Ströbel, Philipp ^a   Reich, Oliver ^b   Michel, Maurice S ^a   Trojan, Lutz ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e UNIVERSIDAD DEL DESARROLLO   (Chile)

^f UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Lymphangiogenesis; Lymphatic metastasis; Prognosis; Urological neoplasms; Vessels

Indexed keywords

VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; BLADDER CANCER; CELL SURVIVAL; CLINICAL RESEARCH; CYSTECTOMY; FLUORESCENCE; GERM CELL TUMOR; GONADAL CELL TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; KNOWLEDGE; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHANGIOGENESIS; LYMPHANGIOGRAPHY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PENIS CANCER; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; REVIEW; SEMINOMA; TERATOMA; TESTIS; TRANSURETHRAL RESECTION; TUMOR CELL; TUMOR GROWTH; UROGENITAL TRACT CANCER;

FORECASTING; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MALE; PROGNOSIS; UROGENITAL NEOPLASMS;

EID: 68849102331     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08704.x     Document Type: Review

References (46)

1. Sanchez-Garcia I. The crossroads of oncogenesis and metastasis. N Engl J Med 2009 360 : 297 9
2. Karpanen T, Alitalo K. Molecular biology and pathology of lymphangiogenesis. Annu Rev Pathol 2008 3 : 367 97
3. Van der Auwera I, Cao Y, Tille JC et al. First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. Br J Cancer 2006 95 : 1611 25
4. Lotan Y, Gupta A, Shariat SF et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 2005 23 : 6533 9
5. Kikuchi E, Margulis V, Karakiewicz PI et al. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 2009 27 : 612 8
6. Bolenz C, Fernandez MI, Trojan L et al. Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis. BJU Int 2009 103 : 1040 6
7. Fernandez MI, Bolenz C, Trojan L et al. Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder. Eur Urol 2008 53 : 571 8
8. Trojan L, Michel MS, Rensch F, Jackson DG, Alken P, Grobholz R. Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1). J Urol 2004 172 : 103 7
9. Trojan L, Rensch F, Voss M et al. The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer. BJU Int 2006 98 : 903 6
10. Stacker SA, Williams RA, Achen MG. Lymphangiogenic growth factors as markers of tumor metastasis. APMIS 2004 112 : 539 49
11. Brakenhielm E, Burton JB, Johnson M et al. Modulating metastasis by a lymphangiogenic switch in prostate cancer. Int J Cancer 2007 121 : 2153 61
12. Miyata Y, Kanda S, Ohba K et al. Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosis. J Urol 2006 176 : 348 53
13. Miyata Y, Kanda S, Ohba K et al. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A-C, and -D. Clin Cancer Res 2006 12 : 800 6
14. Herrmann E, Eltze E, Bierer S et al. VEGF-C, VEGF-D and Flt-4 in transitional bladder cancer: relationships to clinicopathological parameters and long-term survival. Anticancer Res 2007 27 : 3127 33
15. Juttner S, Wissmann C, Jons T et al. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma. J Clin Oncol 2006 24 : 228 40
16. Stacker SA, Achen MG. From anti-angiogenesis to anti-lymphangiogenesis: emerging trends in cancer therapy. Lymphat Res Biol 2008 6 : 165 72
17. Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature 2005 438 : 946 53
18. Roma AA, Magi-Galluzzi C, Kral MA, Jin TT, Klein EA, Zhou M. Peritumoral lymphatic invasion is associated with regional lymph node metastases in prostate adenocarcinoma. Mod Pathol 2006 19 : 392 8
19. Burton JB, Priceman SJ, Sung JL et al. Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis. Cancer Res 2008 68 : 7828 37
20. Cheng L, Bishop E, Zhou H et al. Lymphatic vessel density in radical prostatectomy specimens. Hum Pathol 2008 39 : 610 5
21. Cohen-Kaplan V, Naroditsky I, Zetser A, Ilan N, Vlodavsky I, Doweck I. Heparanase induces VEGF C and facilitates tumor lymphangiogenesis. Int J Cancer 2008 123 : 2566 73
22. Kuroda K, Horiguchi A, Asano T, Hayakawa M. Prediction of lymphatic invasion by peritumoral lymphatic vessel density in prostate biopsy cores. Prostate 2008 68 : 1057 63
23. Wong SY, Haack H, Crowley D, Barry M, Bronson RT, Hynes RO. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis. Cancer Res 2005 65 : 9789 98
24. Yang J, Wu HF, Qian LX et al. Increased expressions of vascular endothelial growth factor (VEGF), VEGF-C and VEGF receptor-3 in prostate cancer tissue are associated with tumor progression. Asian J Androl 2006 8 : 169 75
25. Yano A, Fujii Y, Iwai A, Kawakami S, Kageyama Y, Kihara K. Glucocorticoids suppress tumor lymphangiogenesis of prostate cancer cells. Clin Cancer Res 2006 12 : 6012 7
26. Jennbacken K, Vallbo C, Wang W, Damber JE. Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis. Prostate 2005 65 : 110 6
27. Kaushal V, Mukunyadzi P, Dennis RA, Siegel ER, Johnson DE, Kohli M. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease. Clin Cancer Res 2005 11 : 584 93
28. Zeng Y, Opeskin K, Baldwin ME et al. Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer. Clin Cancer Res 2004 10 : 5137 44
29. Tilki D, Irmak S, Oliveira-Ferrer L et al. CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer. Oncogene 2006 25 : 4965 74
30. Kilic N, Oliveira-Ferrer L, Neshat-Vahid S et al. Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1. Blood 2007 110 : 4223 33
31. Zhang H, Muders MH, Li J, Rinaldo F, Tindall DJ, Datta K. Loss of NKX3. 1 favors vascular endothelial growth factor-C expression in prostate cancer. Cancer Res 2008 68 : 8770 8
32. Clasper S, Royston D, Baban D et al. A novel gene expression profile in lymphatics associated with tumor growth and nodal metastasis. Cancer Res 2008 68 : 7293 303
33. Zu X, Tang Z, Li Y, Gao N, Ding J, Qi L. Vascular endothelial growth factor-C expression in bladder transitional cell cancer and its relationship to lymph node metastasis. BJU Int 2006 98 : 1090 3
34. Szarvas T, Jager T, Totsch M et al. Angiogenic switch of angiopietins-Tie2 system and its prognostic value in bladder cancer. Clin Cancer Res 2008 14 : 8253 62
35. Saban MR, Towner R, Smith N et al. Lymphatic vessel density and function in experimental bladder cancer. BMC Cancer 2007 7 : 219
36. Karakiewicz PI, Trinh QD, Bhojani N et al. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival. Eur Urol 2007 51 : 1616 24
37. Iwata T, Miyata Y, Kanda S et al. Lymphangiogenesis and angiogenesis in conventional renal cell carcinoma: association with vascular endothelial growth factors A to D immunohistochemistry. Urology 2008 71 : 749 54
38. Bierer S, Herrmann E, Kopke T et al. Lymphangiogenesis in kidney cancer: expression of VEGF-C, VEGF-D and VEGFR-3 in clear cell and papillary renal cell carcinoma. Oncol Rep 2008 20 : 721 5
39. Gunningham SP, Currie MJ, Han C et al. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia. Cancer Res 2001 61 : 3206 11
40. Lin J, Lalani AS, Harding TC et al. Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor. Cancer Res 2005 65 : 6901 9
41. Marks A, Sutherland DR, Bailey D et al. Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours. Br J Cancer 1999 80 : 569 78
42. Adam M, Schmidt D, Wardelmann E, Wernert N, Albers P. Angiogenetic protooncogene ets-1 induced neovascularization is involved in the metastatic process of testicular germ cell tumors. Eur Urol 2003 44 : 329 36
43. Fukuda S, Shirahama T, Imazono Y et al. Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease. Cancer 1999 85 : 1323 30
44. Jones A, Fujiyama C, Turner K et al. Angiogenesis and lymphangiogenesis in stage 1 germ cell tumours of the testis. BJU Int 2000 86 : 80 6
45. Hattori H. Caution should be taken in using CD31 for distinguishing the vasculature of lymph nodes. J Clin Pathol 2003 56 : 638 9
46. Naumann CM, Al-Najar A, Alkatout I et al. Lymphatic spread in squamous cell carcinoma of the penis is independent of elevated lymph vessel density. BJU Int 2009 Feb 10 [Epub ahead of print]